ACE inhibitor: characteristics, mechanisms of action, pharmacokinetics, indication, contraindication, clinical data, and side effects
Kuwabara, Y.; Komuro, I.
Nihon Rinsho. Japanese Journal of Clinical Medicine 65(Suppl 5): 66-73
2007
ISSN/ISBN: 0047-1852 PMID: 17571367 Document Number: 606579
Document emailed within 1 workday
Related Documents
Schäfer-Korting, M. 2003: New systemic antifungal drugs: mechanisms of action, drug interactions and side effects Mycoses 46(Suppl): 28-31Christensen, S. 1981: The pharmacology of antihypertensive agents. Sites and mechanisms of action, side effects and contraindications Ugeskrift for Laeger 143(7): 397-403
Katahira, H.; Ishida, H. 2002: Indication and side effect of alpha glucosidase inhibitor Nihon Rinsho. Japanese Journal of Clinical Medicine 60(Suppl 9): 399-408
Shearman, R.P. 1965: The Mechanism of Action of Oral Contraceptives and their Side effects in Clinical Practice Medical Journal of Australia 1(3): 68-70
Yukawa, E.; Mine, H.; Higuchi, S.; Aoyama, T. 1992: Digoxin population pharmacokinetics from routine clinical data: role of patient characteristics for estimating dosing regimens Journal of Pharmacy and Pharmacology 44(9): 761-765
Du Toit, D.F.; Heydenrych, J.J. 1986: The application, mechanism of action and side-effects of immunosuppressive agents in clinical transplantation South African Medical Journal 70(11): 687-691
Morino, M.; Cavuoti, G.; Miglietta, C.; Giraudo, G.; Simone, P. 2000: Laparoscopic cholecystectomy in cirrhosis: contraindication or privileged indication? Surgical Laparoscopy Endoscopy and Percutaneous Techniques 10(6): 360-363
Tashkinov, V.I. 1978: Indication and contraindication for creating transduodenal suprapapillary choledochoduodenostomy Khirurgiia 7: 37-40
Bielory, L.; Russin, J.; Zuckerman, G.B. 2004: Clinical efficacy, mechanisms of action, and adverse effects of complementary and alternative medicine therapies for asthma Allergy and Asthma Proceedings 25(5): 283-291
Merigan, T.C. 1977: Pharmacokinetics and side effects of interferon in man Texas Reports on Biology and Medicine 35: 541-547
Kaspar, U. 1976: Diphenylhydantoin. Metabolism, pharmacokinetics, interactions and side effects Schweizerische Medizinische Wochenschrift 106(23): 777-788
Schnuch, A. 1987: Gyrase inhibitor: central nervous system side effects Deutsche Medizinische Wochenschrift 112(14): 569
Seale, L.R.; Eglini, A.N.; McMichael, A.J. 2016: Side Effects Related to 5 α-Reductase Inhibitor Treatment of Hair Loss in Women: a Review Journal of Drugs in Dermatology: Jdd 15(4): 414-419
Cambau, E. 1996: Antibiotics. General data on modes of action and mechanisms of resistance La Revue du Praticien 46(19): 2343-2350
Gordon, M.; Guralnik, M.; Kaneko, Y.; Mimura, T.; Baker, M.; Lang, W. 1994: A phase i study of curdlan sulfate--an HIV inhibitor. Tolerance, pharmacokinetics and effects on coagulation and on CD4 lymphocytes Journal of Medicine 25(3-4): 163-180
Fomina, I.G.; Minushkin, O.N.; Lidskiĭ, P.I.; Sverchkova, E.I.; Ternovaia, A.S. 1977: Antiarrhythmic action of lidocaine and its side effects Klinicheskaia Meditsina 55(5): 64-70
Pilipchuk, N.S.; Kliachkin, L.M.; Protsiuk, R.G. 1989: Mechanisms of the therapeutic and damaging (side effects) actions of inhalation aerosol therapy Voprosy Kurortologii Fizioterapii i Lechebnoi Fizicheskoi Kultury 1: 21-24
Tollefson, G.D.; Greist, J.H.; Jefferson, J.W.; Heiligenstein, J.H.; Sayler, M.E.; Tollefson, S.L.; Koback, K. 1994: Is baseline agitation a relative contraindication for a selective serotonin reuptake inhibitor: a comparative trial of fluoxetine versus imipramine Journal of Clinical Psychopharmacology 14(6): 385-391
Youle, R J. 2003: Haya Lorberboum-Galski and Philip Lazarovici (Eds.). Chimeric Toxins: Mechanisms of Action and Therapeutic Applications (Cell and Molecular Mechanisms of Toxin Action) International Journal of Toxicology 22(4): 331-332
Hagenfeldt, K. 1980: Prostaglandins: mechanism of action and side effects of intrauterine devices Contraception Fertilite Sexualite 8(9): 669-673